Jaume Lillo
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Quantifying Heteromer Partitioning Reveals Inflammation-Dependent Redistribution of Microglial Adenosine A2A and Cannabinoid CB2 Receptors.
Journal: Glia
Published: January 29, 2026
The Orexin System in Addiction: Neuromodulatory Interactions and Therapeutic Potential.
Journal: Brain sciences
Published: September 05, 2025
The Interplay Between CB2 and NMDA Receptors in Parkinson's Disease.
Journal: International journal of molecular sciences
Published: August 08, 2025
Mechanism of μ-opioid receptor inhibition by orphan GPR88.
Journal: Pharmacological research
Published: July 29, 2025
Metadynamics simulations and site-directed mutagenesis determine the binding of cannabidiol to the adenosine A2A receptor.
Journal: Protein science : a publication of the Protein Society
Published: June 04, 2025
Cannabidiol releases CB1R from A2AR repression in ischemic stroke.
Journal: Neurobiology of disease
Published: April 07, 2025
Cannabinoid CB1 Receptor Activation Mitigates N‑Methyl‑d‑aspartate Receptor-Mediated Neurotoxicity.
Journal: ACS pharmacology & translational science
Published: March 31, 2025
Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function.
Journal: Alzheimer's research & therapy
Published: February 17, 2025
Future Perspectives of NMDAR in CNS Disorders.
Journal: Molecules (Basel, Switzerland)
Published: January 14, 2025
Neuroprotective effects of G9a inhibition and cannabinoid receptor activation in Alzheimer's disease through a pharmacological approach.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: November 26, 2024
Novel protocol for metabolomics data normalization and biomarker discovery in human tears.
Journal: Clinical chemistry and laboratory medicine
Published: November 20, 2024
Last Updated: 09/26/2026